24.11.2014 Views

Misoprostol for induction of labour at term

Misoprostol for induction of labour at term

Misoprostol for induction of labour at term

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ORIGINAL ARTICLE<br />

<strong>Misoprostol</strong> <strong>for</strong> <strong>induction</strong> <strong>of</strong> <strong>labour</strong> <strong>at</strong> <strong>term</strong><br />

53<br />

Arshia Javed, Haleema A Hashmi<br />

Abstract:<br />

Objectives: The purpose <strong>of</strong> this study is to assess the effectiveness <strong>of</strong> 50mg vaginal <strong>Misoprostol</strong><br />

<strong>for</strong> <strong>induction</strong> <strong>of</strong> <strong>labour</strong> <strong>at</strong> <strong>term</strong>.<br />

Design: Retrospective observ<strong>at</strong>ional study.<br />

Setting: Department <strong>of</strong> Obstetrics &Gynaecology, Liaqu<strong>at</strong> N<strong>at</strong>ional Hospital, Karachi, Pakistan<br />

from 1st January 2008 to December 2009.<br />

Methods: Two hundred and twenty one p<strong>at</strong>ients were analyzed; who were induced <strong>at</strong> 37<br />

weeks gest<strong>at</strong>ion and onwards by using 50mg vaginal misoprostol repe<strong>at</strong>ed every 6 hourly <strong>for</strong> a<br />

maximum <strong>of</strong> 3 doses or initi<strong>at</strong>ion <strong>of</strong> active <strong>labour</strong>, to assess the efficacy <strong>of</strong> the drug.<br />

Results: The results were analyzed by using SPSS version 13.0. Among 221 p<strong>at</strong>ients 161<br />

(73%) delivered by vaginal route & 60 (27.1%) p<strong>at</strong>ient had caesarean deliveries. Out <strong>of</strong> these<br />

91 (57%) p<strong>at</strong>ient, delivered within 8 – 12 hours. 22 (9.95%) p<strong>at</strong>ients had Meconium stained<br />

liquor. No case <strong>of</strong> uterine hyperstimul<strong>at</strong>ion and perin<strong>at</strong>al mortality observed.<br />

Conclusion: Vaginal <strong>Misoprostol</strong> was found to be safe and effective drug to use <strong>for</strong> <strong>induction</strong><br />

<strong>of</strong> <strong>labour</strong> with least complic<strong>at</strong>ions.<br />

Keywords: <strong>Misoprostol</strong>, Induction <strong>of</strong> Labour, Term<br />

Department <strong>of</strong><br />

Obstetrics &<br />

Gynaecology,<br />

Liaqu<strong>at</strong> N<strong>at</strong>ional<br />

Hospital,<br />

Stadium Road<br />

Karachi<br />

A Javed<br />

HA Hashmi<br />

Correspondence:<br />

Dr. Arshia Javed<br />

Senior Registrar<br />

Department <strong>of</strong> Obstetrics<br />

&Gynaecology<br />

Liaqu<strong>at</strong> N<strong>at</strong>ional Hospital<br />

N<strong>at</strong>ional Stadium Road<br />

Karachi – PAKISTAN<br />

Cell # 0300-2119180<br />

Pak J Surg 2012; 28(1):53-56<br />

Introduction:<br />

The <strong>induction</strong> <strong>of</strong> <strong>labour</strong> (IOL) is an important<br />

part <strong>of</strong> modern obstetric practice th<strong>at</strong> occurs in<br />

15% <strong>of</strong> all pregnancies. 1 Nearly 27% <strong>of</strong> pregnant<br />

women had their <strong>labour</strong> induced. 2<br />

There are many situ<strong>at</strong>ions in obstetrics when<br />

there is need <strong>for</strong> <strong>labour</strong> <strong>induction</strong>. Generally<br />

<strong>induction</strong> is indic<strong>at</strong>ed when the benefits to either<br />

the mother or the fetus out weight those<br />

<strong>of</strong> continuing the pregnancies. 3 IOL in women<br />

with unripe cervices are frequently prolonged<br />

and very <strong>of</strong>ten unsuccessful, resulting in caesarean<br />

delivery. 4 Studies have established th<strong>at</strong> pre<strong>labour</strong><br />

cervical st<strong>at</strong>us highly correl<strong>at</strong>es with the<br />

inducibility <strong>of</strong> <strong>labour</strong> and th<strong>at</strong> cervical ripening<br />

improves the success <strong>of</strong> <strong>labour</strong> <strong>induction</strong>. 5<br />

<strong>Misoprostol</strong> has become an important drug in<br />

obstetric and gynaecological practice because <strong>of</strong><br />

it’suterotonic and cervical ripening activity and<br />

good safety pr<strong>of</strong>ile compared to other prostaglandin<br />

prepar<strong>at</strong>ion, misoprostol is inexpensive.<br />

It does not require parenteral administr<strong>at</strong>ion or<br />

refriger<strong>at</strong>ion and has few systemic side effects.<br />

It can help save m<strong>at</strong>ernal life by preventing or<br />

tre<strong>at</strong>ing postpartum haemorrhage where other<br />

safe altern<strong>at</strong>ive do not exists. 6<br />

Cochrane pregnancy and childbirth group analyzed<br />

48 randomized trials including > 5400<br />

women have found vaginal misoprostol to be<br />

more effective than oxytocin or vaginal prostaglandin<br />

E2 <strong>for</strong> effective delivery with in 24<br />

hours. 6,7<br />

The aim <strong>of</strong> this study is to assess the effectiveness<br />

<strong>of</strong> 50mg vaginal misoprostol <strong>for</strong> <strong>induction</strong><br />

<strong>of</strong> <strong>labour</strong> <strong>at</strong> <strong>term</strong> with respect to vaginal delivery<br />

within 24 hours, mode <strong>of</strong> delivery, fetal outcome<br />

and m<strong>at</strong>ernal side effects also studied.


54 A Javed, HA Hashmi<br />

M<strong>at</strong>erial and Methods:<br />

This is a retrospective observ<strong>at</strong>ional study conducted<br />

<strong>at</strong> the department <strong>of</strong> obstetrics &gynaecology,<br />

Liaqu<strong>at</strong>N<strong>at</strong>ionalHospital, Karachi,<br />

Pakistan over a period <strong>of</strong> 2 years from 1st January,<br />

2008 to 31st December, 2009. 221 p<strong>at</strong>ient,<br />

were included in the study, who were induced <strong>at</strong><br />

37 weeks <strong>of</strong> gest<strong>at</strong>ion & onwards by using 50mg<br />

vaginal misoprostol to assess the efficacy <strong>of</strong> the<br />

drug.<br />

Inclusion Criteria:<br />

• Singleton viable pregnancy<br />

• Cephalic present<strong>at</strong>ion<br />

• Dur<strong>at</strong>ion <strong>of</strong> gest<strong>at</strong>ion > 37 weeks<br />

• Reactive CTG<br />

Exclusion Criteria:<br />

• Any contraindic<strong>at</strong>ion to vaginal birth<br />

• Previous caesarean section<br />

• Placenta previa<br />

• Moder<strong>at</strong>e to severe abruptio<br />

Women were induced with 50mg misoprostol<br />

placed in the posterior vaginal <strong>for</strong>nix every 6<br />

hours till 3 doses. Women were monitored with<br />

in<strong>term</strong>ittent Cardiotocography and partogram<br />

was plotted. More than 4 uterine contractions <strong>of</strong><br />

40 seconds in 10 minutes were taken as hyperstimul<strong>at</strong>ion.<br />

Results:<br />

The results were analyzed by using SPSS Version<br />

13. The d<strong>at</strong>a represent as percentage as<br />

well as mean, mode and standard devi<strong>at</strong>ion as<br />

being appropri<strong>at</strong>e. Two hundreds and twentyone<br />

p<strong>at</strong>ients were induced with different indic<strong>at</strong>ions<br />

<strong>of</strong> IOL most common indic<strong>at</strong>ion was post<br />

d<strong>at</strong>es (28%). Age range <strong>of</strong> women were 18 – 38<br />

years with mean Age <strong>of</strong> 27.8, 131 p<strong>at</strong>ients were<br />

<strong>of</strong> parity between P0-2 (58.82%) as shown in<br />

Table 1. Vaginal delivery occurred in 161 (73%)<br />

p<strong>at</strong>ient’s & 60 (27%) ended up in caesarean section,<br />

Meconium stained liquor was found in 22<br />

p<strong>at</strong>ietns (9.95%) & 20 p<strong>at</strong>ients had abnormal<br />

CTG (9.04%) as shown in Table 2.<br />

When low apgar score was analyzed 28 (12.6%)<br />

babies had apgar score less than 7 in 1 min & 4<br />

had less than 7 in 5 min (1.8%) Table 3.<br />

No case <strong>of</strong> uterine hyperstimul<strong>at</strong>ion and perin<strong>at</strong>al<br />

mortality observed.<br />

Discussion:<br />

Induction <strong>of</strong> <strong>labour</strong> is a common procedure in<br />

the <strong>labour</strong> ward. it is per<strong>for</strong>med <strong>for</strong> several fetal<br />

& m<strong>at</strong>ernal indic<strong>at</strong>ions. with an unripe cervix<br />

IOL may be difficult and unsuccessful. IOL be<strong>for</strong>e<br />

the cervix is ripe <strong>of</strong>ten results in prolonged<br />

<strong>labour</strong> or failed <strong>induction</strong> with increased risk <strong>of</strong><br />

oper<strong>at</strong>ive delivery & morbidity. 8,9<br />

The use <strong>of</strong> agents to ripen the cervix prior to conventional<br />

methods <strong>of</strong> <strong>induction</strong> is the standard<br />

practice. Vaginal prostaglandin prepar<strong>at</strong>ion have<br />

proved to be beneficial and are now the most<br />

widely used agents in developed countries. 10<br />

<strong>Misoprostol</strong> is a synthetic analogue <strong>of</strong> n<strong>at</strong>urally<br />

occurring prostaglandin E1& it is an effective<br />

drug <strong>for</strong> cervical ripening & labor <strong>induction</strong>.<br />

Although it is not approved by FDA <strong>for</strong> this<br />

indic<strong>at</strong>ion, the AmericanCollege <strong>of</strong> Obstetrics<br />

&Gynaecologist advoc<strong>at</strong>es misoprostol & it is<br />

on WHO essential drug list <strong>for</strong> <strong>labour</strong> <strong>induction</strong>.<br />

It is now licensed <strong>for</strong> <strong>labour</strong> <strong>induction</strong> in<br />

Egypt&Brazil, & a licensed <strong>induction</strong> product<br />

was expected in UK some time in 2008. 11<br />

<strong>Misoprostol</strong> has been safe in IOL in resource<br />

constrained hospital settings in developing<br />

countries like ours, using basic clinical tools <strong>for</strong><br />

monitoring. 12-14<br />

In this study 221 p<strong>at</strong>ients were induced with<br />

50mg vaginal misoprostol. The most common<br />

indic<strong>at</strong>ion <strong>of</strong> IOL was postd<strong>at</strong>e 28%. Majority<br />

<strong>of</strong> the p<strong>at</strong>ient 161 (73%) delivered by vaginal<br />

route. The results are comparable to the study<br />

conducted by Aqeela et al. 15 in which 77% p<strong>at</strong>ients<br />

delivered by vaginal route. A study conducted<br />

by Z. Tabasi et al. 16 also supported the<br />

result in which 72.7% p<strong>at</strong>ients delivered by vaginal<br />

route. Similar results were seen in study by<br />

Shetty et al. 17 .<br />

Caesarean Section r<strong>at</strong>e was found to be 27%<br />

which is comparable to the study by Z. Tasasiet<br />

al. 16 in which 27.3% delivered by caesarean section.<br />

Pak J Surg 2012; 28(1):53-56


<strong>Misoprostol</strong> <strong>for</strong> <strong>induction</strong> <strong>of</strong> <strong>labour</strong> <strong>at</strong> <strong>term</strong><br />

Table 1: Demographic D<strong>at</strong>a <strong>of</strong> Women<br />

M<strong>at</strong>ernal Age (Mean + SD) 27.8 + 97.29<br />

Parity: (Mean + SD) 1.8 + 154.99<br />

P0-2 130<br />

P2-4 70<br />

P4-6 21<br />

Table 2: M<strong>at</strong>ernal Outcome<br />

Mode <strong>of</strong> Delivery<br />

All Vaginal Deliveries 161 73%<br />

Spontancous 124 77%<br />

Assisted 37 23%<br />

Caesarean Section 60 27%<br />

Meconium Stained Liquor 22 9.95%<br />

Abnormal CTG 20 9.04%<br />

Uterine Hyperstimul<strong>at</strong>ion Nil Nil<br />

Induction to delivery interval (Mean+SD) 12.45 ± 105.64<br />

Table 3: Fetal Outcome<br />

Apgar Score<br />

< 7 in 1 min 28 12.6%<br />

< 7 in 5 min 4 1.8%<br />

Perin<strong>at</strong>al Mortality Nil Nil<br />

The p<strong>at</strong>ients delivered within 6 – 8 hours were<br />

9% & 57% were within 8 – 12 hours with mean<br />

<strong>induction</strong> to delivery interval was 12.45. Many<br />

studies have been found same results Z. Tabasiet<br />

al. 16 , Ferzuson et al. 18 , Sahin et al. 19 , Ramsey et<br />

al. 21<br />

Meconium Stained Liquor (MSL) was observed<br />

in 9.95% <strong>of</strong> p<strong>at</strong>ients & 9.04 % p<strong>at</strong>ients had abnormal<br />

Cardiotocography. The other studies<br />

supported the results were <strong>of</strong> Majid N et al<br />

2009 22 in which 12% p<strong>at</strong>ients had MSL.<br />

Most <strong>of</strong> the babies born with good Apgar score<br />

85%, only 13% baby had Apgar score


56 A Javed, HA Hashmi<br />

20. Ramsey, P. S, L. Meyer, B. A. Walkes, D. Harrus, P. L. Jr. Ogburn,<br />

R. H. Heise and K. D Ramin, 2005 Cardiotocographic<br />

abnormalities associ<strong>at</strong>ed with dinoprostone and <strong>Misoprostol</strong><br />

cervical ripening. Obstet .Gynaecol; 105: 85 - 90.<br />

21. Zeteroglu S, G. H. Sahin and H. A Sahin, 2006. Indution <strong>of</strong><br />

<strong>labour</strong> with <strong>Misoprostol</strong> in pregnancies with advanced m<strong>at</strong>ernal<br />

age. Eur. J. Obstet. Gynaecol. Reprod. Biol; Jan. 4. (In<br />

press).<br />

22. Majid N, Nasir F, Akhter T, F<strong>at</strong>ima H. <strong>Misoprostol</strong>: An effective<br />

agent <strong>for</strong> <strong>labour</strong> <strong>induction</strong> in full <strong>term</strong> parous women.<br />

Medical channel. 2009; 15(2): 51 - 54.<br />

Sheikher C, Suri N, Kohli U. Compar<strong>at</strong>ive evalu<strong>at</strong>ion <strong>of</strong> oral<br />

23.<br />

<strong>Misoprostol</strong>, vaginal <strong>Misoprostol</strong> and intra cervical foley’s<br />

c<strong>at</strong>heter <strong>for</strong> <strong>induction</strong> <strong>of</strong> <strong>labour</strong> <strong>at</strong> <strong>term</strong>. JK Science. 2009;<br />

11(2): 75 - 77.<br />

Abbasi N, Danish N, Shakoor F, Perveen Z, Bilal S A. Effective-<br />

24.<br />

ness and safety <strong>of</strong> vaginal <strong>Misoprostol</strong> <strong>for</strong> <strong>induction</strong> <strong>of</strong> <strong>labour</strong><br />

in un favourable cervix in 3rd trimester. J Ayub Med Coll Abbotabad.2008;<br />

20(3): 33 - 5.<br />

Pak J Surg 2012; 28(1):53-56

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!